News from Pharmalink AB A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

29 Mar, 2017, 04:00 ET Positive Results of Phase 2b Clinical Trial of Pharmalink's Nefecon in Primary IgA Nephropathy Published in The Lancet

Pharmalink AB, a specialty pharma company, announces that positive results and analyses from the completed Phase 2b trial of its oral drug...


09 Jan, 2017, 02:00 ET Pharmalink Strengthens Board with Appointment of Maria Carell as Chair

Pharmalink AB, a specialty pharma company, announces the election of Maria Carell as Chair of the company's Board of Directors*. Ms. Carell...


29 Nov, 2016, 04:00 ET Pharmalink Announces European Orphan Drug Designation For Nefecon® For Treatment Of Iga Nephropathy, An Inflammatory Kidney Disease

Pharmalink AB, a specialty pharma company, announces that the European Commission (EC) has granted Orphan Medicinal Product (OMP) designation in...


01 Oct, 2015, 03:00 ET Pharmalink Raises SEK100m to Advance Nefecon® Development as New Treatment for Kidney Disease

Plans Initial Public Offering on Nasdaq Stockholm in 2016  Pharmalink AB, a specialty pharma company, today announces it has raised SEK100...


18 Mar, 2015, 04:00 ET Pharmalink Acquires Novel Therapeutic Product Candidate for Treating Inflammation Associated With Osteoarthritis

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from...


03 Nov, 2014, 03:00 ET Data from Clinical Study of Pharmalink's Nefecon® to be Presented at American Society of Nephrology's Kidney Week 2014

Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that clinical results from the initial run-in phase of...


27 Oct, 2014, 04:00 ET Pharmalink Extends Patent Protection for Nefecon® Treatment for Renal Disease

  Key patent granted in Japan   Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had an important...


10 Jul, 2014, 03:00 ET Pharmalink's Core Patents for Nefecon® Treatment for Renal Disease Granted in United States, Europe, China and Hong Kong

Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate...


13 Jan, 2014, 03:00 ET Pharmalink Completes Enrolment of Patients into Phase IIB Clinical Study (Nefigan) of Nefecon®

Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces it has completed recruitment of patients into a Phase...


18 Dec, 2012, 04:37 ET Pharmalink Initiates a Pivotal Phase IIb Trial with Nefecon® in Patients with Primary IgA Nephropathy

Pharmalink AB, a Swedish specialty pharma company, today announces it has initiated a Phase IIb study with Nefecon® (Nefigan) in patients...


29 Oct, 2012, 05:00 ET Pharmalink AB Strengthens Senior Management Team

Dr. Heather Cook Appointed Director of Regulatory Affairs and Marek Poszepczynski as Director of Business Development Pharmalink AB, a Swedish...


13 Dec, 2011, 04:00 ET Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT® Technology for Nefecon® (PL-56) Program

Pharmalink AB, today announces it has gained an exclusive global license to Archimedes Pharma Ltd.'s TARGIT® drug delivery technology for use...


13 Oct, 2010, 04:00 ET Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56)

Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA)...


30 Jun, 2010, 04:51 ET Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome

- Agreement Marks Milestone in Pharmalink's Corporate Development Pharmalink AB, today announced that it has closed its agreement with Grifols SA...


26 Oct, 2009, 04:00 ET Pharmalink AB Receives Patent for Nefecon(R) Principle

- Japanese Grant Supports Asian Partnering Programme Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods...


29 Apr, 2009, 05:14 ET Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)

- Results to be Presented at World Congress of Nephrology 2009 Pharmalink AB announced today that it has completed its open Phase II trial...


23 Apr, 2009, 03:00 ET Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development

Pharmalink AB today announced that it has strengthened its Board of Directors as the company's portfolio continues to move towards late stage...